Enterotoxins of Vibrio cholerae and Escherichia coli have attracted attention as important causes of diarrhoea1 diseases (Pierce & Wallace, 1972; Holmgren, 1981) . The drastic intestinal secretion of electrolytes and fluid in cholera in man, and the more prevalent but less severe fluid loss in colibacillosis in man as well as in domestic animals, results from action of the enterotoxins on the epithelium of the small intestine (Evans et al., 1972; Sharp, 1973) . This action involves stimulation of adenylate cyclase activity and causes a change from the normal state of absorption to one of a net secretion of electrolytes and fluid.
Different possibilities for a specific pharmacological inhibition of secretion have been studied. An inhibiting effect by the a,-adrenoceptor agonists adrenaline and clonidine has been demonstrated in cholera toxin-induced intestinal hypersecretion in rats (Nakaki et al., 1982) . An antisecretory effect by neuroleptic drugs has been reported by several investigators (Lonnroth et al., 1977; Bunce & Spraggs, 1982; Larsen, 1982; Olsvik et al., 1982; Zavecz et al., 1982) . Chlorpromazine, which belongs to the phenothiazine group, is the most thoroughly studied substance. This drug inhibits cholera toxin-induced hypersecretion in experimental animals (Liinnroth et al., 1977) and it has a good clinical effect in cholera patients (Rabbini et al., 1979) as well as in piglets with enteric colibacillosis (Lonnroth et al., 1979 ). An antisecretory effect might possibly also be obtained with the phenothiazine prochlorperazine. This drug was included as an anti-emetic in Chatterjee's treatment regimen for cholera 30 years ago (Chatterjee, 1953) .
The reports on the antisecretory effects of chlorpromazine and some other neuroleptics (Lonnroth et al., 1977 (Lonnroth et al., , 1980 have stimulated us to investigate (1) the antisecretory effect of various types of neuroleptics, (2) the mechanism of action by comparing the antisecretory potencies with the dopamine-receptor-blocking and sedative potencies of the drugs, and by testing other agents with different pharmacological actions, and (3) whether the site of action is situated inside or outside the central nervous system.
The antisecretory effect was studied in mice in which experimental cholera was induced in an intestinal loop model as described by Lange & Holmgren (1978) . The study included a number of neuroleptics belonging to the phenothiazine, thioxanthene, dibenzodiazepine, butyrophenone, diphenylbutylpiperidine and benzamide groups plus butaclamol, metoclopramide, tefludazine (1-(2-hydroxyethyl)-4-(3 -( p-fluorphenyl)-6-trifluormethyl-1 -indanyl)piperazine) and SCH 23390. Phenothiazines, thioxanthenes and tefludazine block both dopamine D-1-and D-2-receptors. The other drugs are selective D-Zantagonists except for SCH 23390 which is a selective D-1-antagonist (Hyttel, 1983) .
Although they all are neuroleptics these drugs comprise a most divergent series of chemical structures. The effectiveness in the symptomatic treatment of psychoses such as schizophrenia, organic psychoses and the manic phase of manic-depressive illness is common to most of them. Some neuroleptics are also of importance for the control of nausea and vomiting. Others are of value for their antihistaminic or analgesic effect. The pathogenesis of schizophrenia or other psychoses is not clear. It is hypothesized that schizophrenia is a manifestation of hyperactivity in the brain dopaminergic neuron systems. The most relevant effect of all known antipsychotic drugs seems to be blockade of dopamine receptors. Before introduction to the clinic, neuroleptic drugs have been selected by use of animal behavioural tests and receptor-binding studies in brain homogenates and isolated organs. Although most interest has been focused on the dopaminergic system, interactions with other neuron systems have also been investigated. The receptor profile of one neuroleptic from each of the chemical classes described is shown in Fig. 1 where interactions with serotoninergic (5-HT2), a-adrenergic (a,) and histaminergic (H,) receptors have been compared with the affinity for dopamine (D-2) receptors measured using the spiroperidol-binding technique. For haloperidol, pimozide and sulpiride the dopaminergic affinity is dominant whereas for cis(Z)-clopenthixol the serotoninergic and a-adrenergic affinity is higher, although it is still much lower than the dopaminergic affinity. Fluphenazine possesses strong histaminergic affin- The antisecretory potencies of neuroleptics and other agents tested are shown in Table 1 . With few exceptions the active drugs belong to the phenothiazine group or the thioxanthene group. Of the thioxanthenes only the cis(Z)-isomers were active. The dibenzodiazepines, butyrophenones, diphenylbutylpiperidines and benzamides plus SCH 23390, butaclamol, tefludazine and metoclopramide were inactive, except for a few compounds. Among the other substances tested only the calcium antagonist nifedipine significantly inhibited the hypersecretion.
The table also shows the dopamine-receptor-antagonistic potencies of the neuroleptics as measured in the methylphenidate-induced stereotyped gnawing test in mice (Pedersen & Christensen, 1972) , and in the dopamine-receptorcoupled adenylate cyclase inhibition test (Hyttel, 1978) . Lastly, the table includes the sedative potencies of the neuroleptics in mice determined as inhibition of the spontaneous activity in an activity cage.
The antisecretory potencies of the neuroleptics did not correlate with the dopamine-receptor-blocking potencies determined in the methylphenidate test or in the adenylate cyclase assay, but some correlation with the sedative potencies of the drugs was seen. A correlation between the antisecretory potencies in the cholera toxin loop model and the sedative potencies in mice has also been found by Lonnroth & Jennische (1982) who studied the effects of six sedative drugs of quite different origin, namely chlorpromazine, melperone, diazepam, mebumal, ketamine and ethyl alcohol. Since sedation can be caused by interaction with different neuron systems and since none of these neuron systems have been found to play a universal role in the antisecretory effect the significance of this correlation is not clear.
The study on the mechanism of action of the antagonism of the hypersecretion showed that dopaminergic stimulation by means of dopamine, apomorphine or methylphenidate had neither antisecretory nor secretory effect. Furthermore, these agonists or the precursor L-dihydroxyphenylalanine did not attenuate the antisecretory effect of cis(Z)-flupentixol or chlorpromazine. These findings as well as the lack of correlation between the antisecretory potencies and the potencies in the methylphenidate test or the adenylate cyclase assay strongly indicate that dopamine (D-1 or D-2) receptor mechanisms are not involved in the antisecretory effects of the neuroleptics. Involvement of aor b-adrenoceptors, muscarinic receptors, histamine H , -or H,-receptors, 5-HT (type 1 or 2) receptors, y-aminobutyric acid receptors or opiate receptors is implausible because agonists and antagonists to these receptors were without effect. Probably the antidiarrhoeal effect of morphine and loperamide is caused by their effect on intestinal motility rather than on hypersecretion. These two drugs had no effect in our intestinal loop model.
The investigation of whether the site of action of the antisecretory effect of cis(Z)-flupentixol or chlorpromazine is peripheral or central was performed by comparing the antisecretory effect after intramuscular administration with that after intracerebroventricular injection. The same antisecretory effect was achieved with a 1.4-3.2 times smaller peripheral than central dose. In contrast, methylphenidate antagonism required a 2.3-2.8-times higher peripheral than central dose. These results are not conclusive but favour a peripheral site of action, most likely in the intestinal mucosa.
The antisecretory mechanism of chlorpromazine has also been investigated by Ltinnroth & Munck (1980) . In isolated hen intestinal mucosa in which the flux of C1-from serosa to mucosa had been increased with cholera toxin, cyclic VOl. 12 214 BIOCHEMICAL SOCIETY TRANSACTIONS AMP or cyclic GMP, or in which the C1-flux was not changed, chlorpromazine increased the flux of C1-in the direction from mucosa to serosa. The action of chlorpromazine on the intestinal fluid transport most probably involves more than one mechanism of action. In a study by Jennische & Lonnroth (1982) two actions are proposed: (1) a reversal of the enterotoxin-induced hypersecretion through an inhibition of the cyclic AMP synthesis and (2) an enhancement of fluid absorption, which probably is not mediated by cyclic AMP. The ability of chlorpromazine to inhibit dopamine or hormone stimulation of cyclic AMP forrilation has earlier been demonstrated in several different tissues. Morphological changes in the rat intestinal mucosa following intramuscular administration of 5 mg of the drug have been reported (Olsvik et al., 1982) . Scanning electron microscopy revealed damage of the secretory epithelium characterized by reduced adherence of the epithelial cells to the basement membrane followed by cell destruction. The suggested hypothesis that chlorpromazine inhibits the hypersecretion by damaging the secretory cells does not appear to be in agreement with its enhancing effect on the fluid absorption in rat jejunum (Jennische & Lonnroth, 1982) and its short-lasting effect in cholera patients (Rabbini et al., 1979) .
It is highly probable that calcium plays a key role in the regulation of intestinal absorption and secretion. Some investigators have speculated that chlorpromazine may inhibit the intestinal hypersecretion by binding to the calcium-regulating protein calmodulin (Zavecz et al., 1982) . The affinities of chlorpromazine, promethazine and some other drugs for calmodulin seem to correlate with the antisecretory effects of the drugs. Furthermore, the calcium antagonist nifedipine was active in our loop model. Cassuto et al. (1983) have suggested that nervous reflexes are involved in the cholera toxin-induced secretion and that these nervous reflexes at least include a cholinergic neuron and a more distal situated neuron containing vasoactive intestinal polypeptide as neurotransmitter. In their experiments in rats and cats, cholera toxin-induced hypersecretion was inhibited by intravenous administration of hexamethonium, or by application of tetrodotoxin or lidocain on the serosal surface of the small intestine.
In our study on the inhibitory effect of neuroleptics on cholera toxin-induced secretion only the effect on the jejunum was examined. The important role of the colon in the total intestinal water balance was underlined by Bunce & Spraggs (1982) who studied the inhibitory effect of chlorpromazine on combined prostaglandin E, -and theophylline-induced secretion in the ileum as well as in the colon of anaesthetized rats. In the ileum chlorpromazine produced a dose-dependent antisecretory effect which was complete at a high dose level. In the colon chlorpromazine was about ten times less potent and even high dosages only partially reversed the net fluxes of water and Na+.
Estimations on the frequency of acute diarrhoea indicate that about 1000 million cases occur among children in Africa, Asia and Latin America during 1 year, resulting in about 5 million deaths. Also, in industrial countries, diarrhoea1 episodes cause many deaths among children. In adults all over the world severe illness or death is frequently caused by diarrhoea. Although the studies in our, as well as in other, laboratories on the antisecretory effect of neuroleptics have not defined the mechanism of action the results appear promising for possible development of new antisecretory drugs.
